This compound is a nucleoside phosphoramidite building block designed for oligonucleotide synthesis. It features a DMT-protected 5'-hydroxyl group and a cyanoethyl phosphoramidite moiety at the 3'-position, enabling automated solid-phase DNA/RNA assembly.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 2747890-15-7
DMTr-TNA-5MeU amidite
nucleoside phosphoramidite for oligonucleotide synthesis
2'-O-Hexadecyl-U-CE-Phosphoramidite
nucleoside phosphoramidite for oligonucleotide synthesis
Thymidine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
nucleoside phosphoramidite for oligonucleotide synthesis
Ac-dA Phosphoramidite
nucleoside phosphoramidite for oligonucleotide synthesis
TERT-BUTYL (2S)-2-AMINO-4-METHYLPENTANOATE HYDROCHLORIDE
Leucine derivative pharmaceutical intermediate
Alogliptin Impurity 4
Pharmaceutical impurity reference standard
L-Alaninol
pharmaceutical intermediate for peptide synthesis
3H-Pyrazol-3-one, 2,4-dihydro-2,5-dimethyl-
pharmaceutical intermediate
3-[[(2R,3R,4R,5R)-2-[(1S)-1-[bis(4-methoxyphenyl)-phenylmethoxy]ethyl]-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
PKWBIYABXKYVJR-UYALASEFSA-N
C[C@@H]([C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)OC)OP(N(C(C)C)C(C)C)OCCC#N)OC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC
—